The Janus family of kinases (JAKs) has been shown to be involved in the signal transduction of a number of cytokine receptors. Recently, we have cloned a novel JAK family member, JAK3, that is expressed in natural killer and activated T cells and is coupled functionally and physically to the interleukin 2 (IL-2) receptor in these cells. Here we report that JAK3 was expressed at low but detectable levels in human monocytes. In contrast, JAK3 expression was strongly induced during activation by interferon gamma (IFN-gamma) or lipopolysaccharide. Moreover, JAK3 became tyrosine phosphorylated in response to IL-2, IL-4, and IL-7 but not response to IFN-gamma or granulocyte/macrophage colony-stimulating factor. Together, these findings suggest that JAK3 is functionally important in activated monocytes and cells of the myeloid lineage and is involved in signaling responses of cytokines that use the common gamma-chain of the IL-2 receptor.
Skip Nav Destination
Article navigation
1 April 1995
Article|
April 01 1995
Regulation of JAK3 expression in human monocytes: phosphorylation in response to interleukins 2, 4, and 7.
T Musso,
T Musso
Biological Carcinogenesis and Development Program, Program Resources, Inc./DynCorp, Frederick, Maryland 21702-1201, USA.
Search for other works by this author on:
J A Johnston,
J A Johnston
Biological Carcinogenesis and Development Program, Program Resources, Inc./DynCorp, Frederick, Maryland 21702-1201, USA.
Search for other works by this author on:
D Linnekin,
D Linnekin
Biological Carcinogenesis and Development Program, Program Resources, Inc./DynCorp, Frederick, Maryland 21702-1201, USA.
Search for other works by this author on:
L Varesio,
L Varesio
Biological Carcinogenesis and Development Program, Program Resources, Inc./DynCorp, Frederick, Maryland 21702-1201, USA.
Search for other works by this author on:
T K Rowe,
T K Rowe
Biological Carcinogenesis and Development Program, Program Resources, Inc./DynCorp, Frederick, Maryland 21702-1201, USA.
Search for other works by this author on:
J J O'Shea,
J J O'Shea
Biological Carcinogenesis and Development Program, Program Resources, Inc./DynCorp, Frederick, Maryland 21702-1201, USA.
Search for other works by this author on:
D W McVicar
D W McVicar
Biological Carcinogenesis and Development Program, Program Resources, Inc./DynCorp, Frederick, Maryland 21702-1201, USA.
Search for other works by this author on:
T Musso
Biological Carcinogenesis and Development Program, Program Resources, Inc./DynCorp, Frederick, Maryland 21702-1201, USA.
J A Johnston
Biological Carcinogenesis and Development Program, Program Resources, Inc./DynCorp, Frederick, Maryland 21702-1201, USA.
D Linnekin
Biological Carcinogenesis and Development Program, Program Resources, Inc./DynCorp, Frederick, Maryland 21702-1201, USA.
L Varesio
Biological Carcinogenesis and Development Program, Program Resources, Inc./DynCorp, Frederick, Maryland 21702-1201, USA.
T K Rowe
Biological Carcinogenesis and Development Program, Program Resources, Inc./DynCorp, Frederick, Maryland 21702-1201, USA.
J J O'Shea
Biological Carcinogenesis and Development Program, Program Resources, Inc./DynCorp, Frederick, Maryland 21702-1201, USA.
D W McVicar
Biological Carcinogenesis and Development Program, Program Resources, Inc./DynCorp, Frederick, Maryland 21702-1201, USA.
Online ISSN: 1540-9538
Print ISSN: 0022-1007
J Exp Med (1995) 181 (4): 1425–1431.
Citation
T Musso, J A Johnston, D Linnekin, L Varesio, T K Rowe, J J O'Shea, D W McVicar; Regulation of JAK3 expression in human monocytes: phosphorylation in response to interleukins 2, 4, and 7.. J Exp Med 1 April 1995; 181 (4): 1425–1431. doi: https://doi.org/10.1084/jem.181.4.1425
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement